Metoprolol Teva

Metoprolol succinate, the active ingredient in Metoprolol Teva, is a beta blocker presented as an oral tablet for oral use. It is used to lower high blood pressure, relieve chest pain from angina, and improve outcomes in chronic heart failure and after myocardial infarction. The medication works by selectively blocking β1‑adrenergic receptors, reducing heart rate and myocardial workload.

GNH USA supplies Metoprolol Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoprolol Teva is a selective β1‑blocker indicated for several cardiovascular conditions. - Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain during exertion. - Chronic heart failure: improves left‑ventricular function and reduces hospitalization. - Post‑myocardial infarction: lowers the chance of recurrent ischemic events and mortality.

Metoprolol Teva may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Fatigue: feeling unusually tired or weak. - Dizziness: light‑headedness, especially when standing quickly. - Bradycardia: slower than normal heart rate. - Cold extremities: reduced blood flow to hands and feet. - Gastrointestinal upset: nausea or abdominal discomfort.

Serious or Rare Side Effects: - Severe bradycardia: heart rate dropping to dangerously low levels. - Heart block: impaired electrical conduction in the heart. - Hypotension: markedly low blood pressure causing fainting. - Bronchospasm: tightening of airway muscles, especially in asthmatic patients. - Depression or mood changes: new or worsening depressive symptoms.

Before initiating Metoprolol Teva, clinicians should assess patient history and monitor specific parameters. - Cardiovascular assessment: evaluate heart rate, blood pressure, and conduction abnormalities. - Respiratory conditions: use cautiously in patients with asthma or chronic obstructive pulmonary disease. - Diabetes management: monitor blood glucose as β‑blockade may mask hypoglycaemia symptoms. - Thyroid disorders: adjust dose in hyper‑ or hypothyroid patients. - Drug discontinuation: taper gradually to avoid rebound tachycardia or hypertension. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Metoprolol Teva can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Non‑selective β‑blockers: additive bradycardia and hypotension. - Calcium channel blockers (verapamil, diltiazem): profound heart‑rate slowing and AV‑block risk. - Antidiabetic agents: may mask hypoglycaemia signs.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): possible increase in plasma metoprolol levels. - NSAIDs: may reduce antihypertensive effect. - Antihypertensives (ACE inhibitors, ARBs): monitor for excessive blood‑pressure lowering.